PolyPeptide Group

About PolyPeptide Group

PolyPeptide Group is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India.

  • SE
  • 2015
    On CPHI since
  • 1000 - 4999
Company types
Primary activities
Contract Manufacturer
Cosmetic Ingredients
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from PolyPeptide Group (5)

  • Semaglutide

    Product Semaglutide

    Semaglutide is an analog of glucagon-like peptide-1 (GLP-1). It is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus. And also, to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established c...
  • Desmopressin

    Product Desmopressin

    Desmopressin is an analogue of the human antidiuretic hormone, vasopressin. It mimics the action of vasopressin on the kidneys to increase the reabsorption of water thereby reducing the volume of urine produced. Desmopressin is a synthetic cyclic nonapeptide, available as the acetate.
  • Leuprolide

    Product Leuprolide

    Leuprolide Acetate is an analogue of Gonadorelin with similar properties. It is used for the treatment of prostate cancer. Furthermore, it is used for the treatment of central precocious puberty and in the management of endometriosis.
  • Octreotide

    Product Octreotide

    Octreotide Acetate is an octapeptide analogue of somatostatin with similar properties, but with a longer duration of action. The product is offered in countries where the patents have expired.
  • Vasopressin

    Product Vasopressin

    Vasopressin, (Arg-Vasopressin, Argipressin) is used for the treatment of diabetes insipidus, in emergency management of haemorrhaging esophageal varices, in the management of acute upper gastrointestinal bleeding and in prevention and control of abdominal distension.